
Celia C Chang
Examiner (ID: 11313, Phone: (571)272-0679 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1612, 1625, 1202, 1203, 2899 |
| Total Applications | 3041 |
| Issued Applications | 1838 |
| Pending Applications | 177 |
| Abandoned Applications | 1031 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8435595
[patent_doc_number] => 08283364
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-09
[patent_title] => 'Compounds which have activity at M1 receptor and their uses in medicine'
[patent_app_type] => utility
[patent_app_number] => 12/088465
[patent_app_country] => US
[patent_app_date] => 2006-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21449
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12088465
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/088465 | Compounds which have activity at M1 receptor and their uses in medicine | Sep 26, 2006 | Issued |
Array
(
[id] => 13933
[patent_doc_number] => 07803816
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-28
[patent_title] => 'MCH receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/526523
[patent_app_country] => US
[patent_app_date] => 2006-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20548
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/803/07803816.pdf
[firstpage_image] =>[orig_patent_app_number] => 11526523
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/526523 | MCH receptor antagonists | Sep 24, 2006 | Issued |
Array
(
[id] => 5242966
[patent_doc_number] => 20070021461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'PROCESSES FOR PREPARING ANHYDROUS AND HYDRATE FORMS OF ANTIHISTAMINIC PIPERIDINE DERIVATIVES, POLYMORPHS AND PSEUDOMORPHS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/534828
[patent_app_country] => US
[patent_app_date] => 2006-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7601
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20070021461.pdf
[firstpage_image] =>[orig_patent_app_number] => 11534828
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/534828 | Methods of treating allergic reactions using hydrated forms of antihistaminic piperidine derivatives | Sep 24, 2006 | Issued |
Array
(
[id] => 7591227
[patent_doc_number] => 07662835
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-16
[patent_title] => 'Methods of treating allergic reactions using an anhydrous form of antihistaminic piperidine derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/534839
[patent_app_country] => US
[patent_app_date] => 2006-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7688
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/662/07662835.pdf
[firstpage_image] =>[orig_patent_app_number] => 11534839
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/534839 | Methods of treating allergic reactions using an anhydrous form of antihistaminic piperidine derivatives | Sep 24, 2006 | Issued |
Array
(
[id] => 53275
[patent_doc_number] => 07772223
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-10
[patent_title] => 'Carboxamide derivatives as muscarinic receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/522840
[patent_app_country] => US
[patent_app_date] => 2006-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63029
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/772/07772223.pdf
[firstpage_image] =>[orig_patent_app_number] => 11522840
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/522840 | Carboxamide derivatives as muscarinic receptor antagonists | Sep 17, 2006 | Issued |
Array
(
[id] => 152305
[patent_doc_number] => 07678915
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-16
[patent_title] => 'Process for production of piperidine derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/521820
[patent_app_country] => US
[patent_app_date] => 2006-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11032
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/678/07678915.pdf
[firstpage_image] =>[orig_patent_app_number] => 11521820
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/521820 | Process for production of piperidine derivatives | Sep 14, 2006 | Issued |
Array
(
[id] => 42916
[patent_doc_number] => 07781461
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-24
[patent_title] => 'NPY Y5 antagonist'
[patent_app_type] => utility
[patent_app_number] => 11/520772
[patent_app_country] => US
[patent_app_date] => 2006-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47331
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/781/07781461.pdf
[firstpage_image] =>[orig_patent_app_number] => 11520772
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/520772 | NPY Y5 antagonist | Sep 13, 2006 | Issued |
Array
(
[id] => 5142588
[patent_doc_number] => 20070004804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Polymorphic forms of nateglinide'
[patent_app_type] => utility
[patent_app_number] => 11/516363
[patent_app_country] => US
[patent_app_date] => 2006-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 64
[patent_figures_cnt] => 64
[patent_no_of_words] => 15398
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20070004804.pdf
[firstpage_image] =>[orig_patent_app_number] => 11516363
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/516363 | Polymorphic forms of nateglinide | Sep 4, 2006 | Abandoned |
Array
(
[id] => 5113681
[patent_doc_number] => 20070197597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-23
[patent_title] => 'Process for the preparation of tryptase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/469599
[patent_app_country] => US
[patent_app_date] => 2006-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17708
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20070197597.pdf
[firstpage_image] =>[orig_patent_app_number] => 11469599
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/469599 | Process for the preparation of tryptase inhibitors | Aug 31, 2006 | Abandoned |
Array
(
[id] => 4572706
[patent_doc_number] => 07829557
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-09
[patent_title] => '2-heterosubstituted 3-aryl-4H-1-benzopyran-4-ones as novel therapeutics in breast cancer'
[patent_app_type] => utility
[patent_app_number] => 11/511192
[patent_app_country] => US
[patent_app_date] => 2006-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6276
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/829/07829557.pdf
[firstpage_image] =>[orig_patent_app_number] => 11511192
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/511192 | 2-heterosubstituted 3-aryl-4H-1-benzopyran-4-ones as novel therapeutics in breast cancer | Aug 27, 2006 | Issued |
Array
(
[id] => 5242910
[patent_doc_number] => 20070021405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'ARYL- AND HETEROARYLPIPERIDINECARBOXYLATE-DERIVATIVES METHODS FOR THEIR PREPARATION AND USE THEREOF AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 11/465238
[patent_app_country] => US
[patent_app_date] => 2006-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12365
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20070021405.pdf
[firstpage_image] =>[orig_patent_app_number] => 11465238
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/465238 | ARYL- AND HETEROARYLPIPERIDINECARBOXYLATE-DERIVATIVES METHODS FOR THEIR PREPARATION AND USE THEREOF AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS | Aug 16, 2006 | Abandoned |
Array
(
[id] => 5107746
[patent_doc_number] => 20070066624
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'Chemokine receptor binding compounds'
[patent_app_type] => utility
[patent_app_number] => 11/505669
[patent_app_country] => US
[patent_app_date] => 2006-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 159870
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0066/20070066624.pdf
[firstpage_image] =>[orig_patent_app_number] => 11505669
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/505669 | Chemokine receptor binding compounds | Aug 15, 2006 | Abandoned |
Array
(
[id] => 32913
[patent_doc_number] => 07790751
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-07
[patent_title] => 'Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands'
[patent_app_type] => utility
[patent_app_number] => 11/504243
[patent_app_country] => US
[patent_app_date] => 2006-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17887
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/790/07790751.pdf
[firstpage_image] =>[orig_patent_app_number] => 11504243
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/504243 | Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands | Aug 13, 2006 | Issued |
Array
(
[id] => 33621
[patent_doc_number] => 07786143
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-31
[patent_title] => 'Thiazolyl piperidine derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/502552
[patent_app_country] => US
[patent_app_date] => 2006-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15316
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/786/07786143.pdf
[firstpage_image] =>[orig_patent_app_number] => 11502552
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/502552 | Thiazolyl piperidine derivatives | Aug 9, 2006 | Issued |
Array
(
[id] => 5096184
[patent_doc_number] => 20070117793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-24
[patent_title] => 'Compounds Which Inhibit Beta-Secretase Activity and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 11/463558
[patent_app_country] => US
[patent_app_date] => 2006-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51048
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20070117793.pdf
[firstpage_image] =>[orig_patent_app_number] => 11463558
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/463558 | Compounds which inhibit beta-secretase activity and methods of use | Aug 8, 2006 | Issued |
Array
(
[id] => 5689077
[patent_doc_number] => 20060287392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'GABAPENTIN COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 11/461830
[patent_app_country] => US
[patent_app_date] => 2006-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 8917
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20060287392.pdf
[firstpage_image] =>[orig_patent_app_number] => 11461830
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/461830 | GABAPENTIN COMPOSITIONS | Aug 1, 2006 | Abandoned |
Array
(
[id] => 4814001
[patent_doc_number] => 20080194632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'Novel Piperidine Derivatives as Chemokine Receptor Modulators Useful for the Treatment of Respiratory Diseases'
[patent_app_type] => utility
[patent_app_number] => 11/997474
[patent_app_country] => US
[patent_app_date] => 2006-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8436
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20080194632.pdf
[firstpage_image] =>[orig_patent_app_number] => 11997474
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/997474 | Novel Piperidine Derivatives as Chemokine Receptor Modulators Useful for the Treatment of Respiratory Diseases | Jul 30, 2006 | Abandoned |
Array
(
[id] => 4823373
[patent_doc_number] => 20080227817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'New Salt I'
[patent_app_type] => utility
[patent_app_number] => 11/997500
[patent_app_country] => US
[patent_app_date] => 2006-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7680
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20080227817.pdf
[firstpage_image] =>[orig_patent_app_number] => 11997500
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/997500 | Salt I | Jul 30, 2006 | Issued |
Array
(
[id] => 4765690
[patent_doc_number] => 20080176902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-24
[patent_title] => 'Salt III'
[patent_app_type] => utility
[patent_app_number] => 11/997489
[patent_app_country] => US
[patent_app_date] => 2006-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4814
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20080176902.pdf
[firstpage_image] =>[orig_patent_app_number] => 11997489
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/997489 | Salt III | Jul 30, 2006 | Abandoned |
Array
(
[id] => 4840465
[patent_doc_number] => 20080280951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-13
[patent_title] => 'Salt Il'
[patent_app_type] => utility
[patent_app_number] => 11/997513
[patent_app_country] => US
[patent_app_date] => 2006-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5919
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20080280951.pdf
[firstpage_image] =>[orig_patent_app_number] => 11997513
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/997513 | Salt Il | Jul 30, 2006 | Abandoned |